Results 291 to 300 of about 236,526 (353)
Abstract Background Persimmon (Diospyros kaki Thunb.) byproducts are a remarkable source of bioactive compounds, particularly carotenoids. Several studies suggest that carotenoids have beneficial effects in prevention of a large number of diseases. This study aims to highlight the effects of a persimmon carotenoid extract (PSCE) rich in β‐cryptoxanthin
Bryan Moreno‐Chamba +10 more
wiley +1 more source
Cumulative Effect of Metabolic Factors on Hepatic Steatosis. [PDF]
Egresi A +9 more
europepmc +1 more source
AI‐Driven Fetal Liver Echotexture Analysis
Objectives To evaluate the performance of artificial intelligence (AI)‐based models in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Methods This diagnostic accuracy study analyzed ultrasound images of fetal livers from pregnancies between 37 and 42 weeks, including cases with and without gestational diabetes ...
Karine S Da Correggio +6 more
wiley +1 more source
Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression. [PDF]
Huang Z +8 more
europepmc +1 more source
Imarkers of early diagnostics of liver steatosis in patients with ischemic heart disease
N. S. Mykhailovska +3 more
openalex +2 more sources
ABSTRACT This study examines the impact of hepatitis C virus (HCV) eradication through sofosbuvir/velpatasvir (SOF/VEL) treatment on glycated hemoglobin (HbA1c) levels in patients with chronic hepatitis C and type 2 diabetes mellitus (T2DM). Utilizing data from the Taiwan HCV Registry, a retrospective analysis was conducted on 2180 patients who met the
Szu‐Jen Wang +43 more
wiley +1 more source
Computed Tomography Radiomics and Machine Learning for Prediction of Histology-Based Hepatic Steatosis Scores. [PDF]
Chu WT +15 more
europepmc +1 more source
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih +21 more
wiley +1 more source

